Laurion Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Laurion Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,444	Closed	-$964K	–	721
2023 Q2	$964K	Buy	+4,444	New	+$952K	0.01%	370
2020 Q3	–	Sell	-53,643	Closed	-$5.98M	–	1214
2020 Q2	$5.98M	Sell	53,643 -93,364	-64%	-$8.12M	0.07%	207
2020 Q1	$10.6M	Buy	+147,007	New	+$12.6M	0.12%	165
2019 Q3	–	Sell	-50,000	Closed	-$1M	–	1338
2019 Q2	$1M	Buy	+50,000	New	+$1M	0.01%	566

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Laurion Capital Management's KRTX Position: Q3 2023 in Review

Laurion Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 4,444 shares — an estimated $964K sold.

Laurion Capital Management first reported a position in KRTX in Q2 2019 and held it in 4 quarters. The position peaked at $10.6M in Q1 2020. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

Laurion Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 4,444 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $964K.
Laurion Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Laurion Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $10.6M in Q1 2020.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.